Soligenix Inc (SNGX)
0.319
-0.03
(-8.86%)
USD |
NASDAQ |
May 31, 16:00
0.311
-0.01
(-2.51%)
After-Hours: 20:00
Soligenix SG&A Expense (Quarterly): 1.022M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.022M |
December 31, 2023 | 1.384M |
September 30, 2023 | 0.973M |
June 30, 2023 | 0.8905M |
March 31, 2023 | 1.235M |
December 31, 2022 | 1.442M |
September 30, 2022 | 1.326M |
June 30, 2022 | 1.383M |
March 31, 2022 | 2.542M |
December 31, 2021 | 1.850M |
September 30, 2021 | 1.147M |
June 30, 2021 | 1.063M |
March 31, 2021 | 0.9493M |
December 31, 2020 | 1.906M |
September 30, 2020 | 0.7684M |
June 30, 2020 | 0.7858M |
March 31, 2020 | 0.8687M |
December 31, 2019 | 1.048M |
September 30, 2019 | 0.7893M |
June 30, 2019 | 0.7691M |
March 31, 2019 | 0.8742M |
December 31, 2018 | 0.9104M |
September 30, 2018 | 0.6678M |
June 30, 2018 | 0.6508M |
March 31, 2018 | 0.7316M |
Date | Value |
---|---|
December 31, 2017 | 0.8862M |
September 30, 2017 | 0.7118M |
June 30, 2017 | 0.8469M |
March 31, 2017 | 0.7642M |
December 31, 2016 | 0.9026M |
September 30, 2016 | 0.6508M |
June 30, 2016 | 0.9996M |
March 31, 2016 | 0.8759M |
December 31, 2015 | 1.065M |
September 30, 2015 | 0.8395M |
June 30, 2015 | 0.875M |
March 31, 2015 | 0.8173M |
December 31, 2014 | 0.9664M |
September 30, 2014 | 0.7304M |
June 30, 2014 | 0.8663M |
March 31, 2014 | 0.8409M |
December 31, 2013 | 0.8468M |
September 30, 2013 | 0.7107M |
June 30, 2013 | 0.7197M |
March 31, 2013 | 0.4879M |
December 31, 2012 | 0.7918M |
September 30, 2012 | 0.5589M |
June 30, 2012 | 0.6272M |
March 31, 2012 | 0.655M |
December 31, 2011 | 0.5678M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.7684M
Minimum
Sep 2020
2.542M
Maximum
Mar 2022
1.207M
Average
1.056M
Median
SG&A Expense (Quarterly) Benchmarks
Eagle Pharmaceuticals Inc | 27.65M |
Marinus Pharmaceuticals Inc | 18.63M |
Inari Medical Inc | 103.06M |
NovaBay Pharmaceuticals Inc | 3.346M |
Palatin Technologies Inc | 2.033M |